Clinical Trial Update: Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating melperone for psychosis in Parkinson's disease has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Psychotic Disorders

Drugs mentioned

• Melperone (melperone)

Snippet

Sponsor: Lundbeck LLC | Conditions: Parkinson's Disease, Psychotic Disorders | Phase 2 | Status: COMPLETED | Results posted: 2011-06-17